ADS:
Inflammation of the prostate gland, especially of the chronic form, is a widespread disease that is currently not fully investigated and difficult to treat. It often occurs in middle-aged males. The consequences of refusal to treat prostatitis are prostate adenomas, oncological diseases.
It is customary for medical researchers to distinguish between bacterial and non-bacterial chronic inflammatory processes of the prostate gland. The first type tends to qualify as an infectious inflammatory disease with the possibility of autoimmune disorders. The mechanism by which non-bacterial inflammation of the prostate gland develops has not yet been studied, and therefore there are no exact data.
Longidaza for chronic prostatitis is a suppository for rectal use, which is prescribed to patients with chronic prostatitis and other forms of this pathology. Inflammation of the prostate gland is diagnosed in males from 30 years old in the infectious or non-bacterial type.
The onset of inflammation of the prostate is often infectious and inflammatory processes, which are aggravated and supported by autoimmune reactions.
Infection of the prostate gland appears as a consequence of such pathologies:
Men who suffer from this pathology tend to complain of pain when urinating, a constant desire to empty the urinary tract due to the pressure of the prostate on it, a decrease in sexual desire, and the disappearance of male power. In the treatment of prostatitis, therapy for inflammation of the prostate gland should be initially focused on eliminating the focus of infectious origin, normalizing immune systems, reducing inflammation, and restoring the working capacity of the prostate.
In order to stop the inflammatory process in the prostate and carry out preventive work on replacing healthy tissues with fibrous ones, hyaluronidase enzymes are extensively used. Longidaza suppositories for prostatitis are one of the medications that contain this enzyme, as a fundamental active element from the entire composition of the drug.
The drug is based on certain combinations of hyaluronidase and polyxidonium. Due to these elements, the beneficial properties of active enzymes increase, causing the treatment of prostatitis. The uniqueness of the Longidase preparation lies in the fact that its effect does not apply to the state of healthy tissues, but is focused only on the changed ones.
Inflammatory processes of the prostate gland are reduced due to changes in the structural component of the connective tissues. Longidaza, participating in the treatment of prostatitis, helps to reduce pain when emptying the urinary canal, to increase the effectiveness of antibiotic therapy.
Indications for the use of the drug are the presence of such pathologies:
The main contraindication is individual intolerance to the individual components of the drug. Suppositories from prostatitis are contraindicated in children under 12 years of age and with cancer. The drug is practically not prescribed in case of insufficient kidney performance.
Of the side effects, painful sensations of the anal passage can be distinguished when a man introduces suppositories for prostatitis. Medical workers rarely meet allergic reactions from the use of suppositories.
The methods of taking the drug are distinguished individually, depending on the form and stage of the disease. The doctor prescribes a course of therapy, up to about 15 injections. The intermediate time between injections is up to ten days. The dosage is determined by the health worker, it depends on the degree of aggravation of the pathology, the age category of the patient, and other aspects.
Longidaza suppositories are used in the following way: one suppository is inserted into the anus before going to bed. When the patient starts treatment, suppositories are injected daily, and, starting from the fifth day, once every two days. The course involves the use of ten suppositories. Self-therapy is unacceptable, the dosage and duration of the course is determined only by the attending physician.
Longidaza has gained wide popularity among patients trying to heal various forms of prostate inflammation. The drug restores the general functionality and muscle tone of the prostate, allowing the pathology to go into remission as soon as possible. The drug helps to reduce the swelling of the prostate gland, strengthens the immune system, prevents the fibrous membrane from gaining integrity.
Active ingredients improve the flow of plasma in the tissue system of the prostate, reduce the viscosity of connective tissues, and increase the permeability of cell membranes. Since the agent promotes the passage of fluid through the cells, the components improve the rate of penetration of antibiotic elements into the gland tissue.
In order to achieve an early positive result from therapy, Longidaza is prescribed in conjunction with the use of an antibiotic. This aspect can significantly speed up the patient's complete recovery. Men, using Longidase, as a drug for inflammation of the prostate gland, normalize the efficiency of the urethra, relieve pain. In fact, the drug is well tolerated, there are no unwanted side effects.
Numerous clinical studies have established that when using Longidaza suppositories, pathological symptoms are significantly reduced, pain and discomfort are instantly stopped, the prostate gland is reduced in size, plasma flow to male organs is normalized, and fibrous tissues are reduced.
After graduating from the complex course of taking suppositories, patients undergoing therapy did not complain of relapses of pathology for a long time. Medical researchers in the field of urology tend to use repeated courses of treatment, but not earlier than after three to four months.
Supportive therapeutic manipulation is to use one candle every seven days. Also, doctors admit the possibility of monotherapy with suppositories.
The effect of the drug with a duration will provide a simple, convenient application, because the active ingredients begin to take effect an hour after ingestion, maintaining an effective result for up to four days. But it must be remembered that any competent therapy is drawn up only after the tests have been passed and the diagnosis is made by the urologist.